Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | HALO | KRYS | ||
| Company | Apellis Pharmaceuticals Inc | Halozyme Therapeutic | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 42.63 | 45.20 | 166.90 | ||
| High | 43.99 | 45.88 | 174.49 | ||
| Low | 42.05 | 45.08 | 166.90 | ||
| Last | 43.60 | 45.48 | 169.25 | ||
| Change | +1.04 | -0.06 | +2.42 | ||
| % Change | +2.44% | -0.13% | +1.45% | ||
| Volume | 1,259,800 | 843,300 | 338,800 | ||
| 20-Day Average Volume | 1,768,410 | 1,017,085 | 268,065 | ||
| Previous Close | 42.56 | 45.54 | 166.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.46 | 42.17 | 160.02 | ||
| 20-Day Raw Stochastic | 42.17% | 91.70% | 82.80% | ||
| 20-Day Relative Strength | 41.27% | 67.99% | 56.97% | ||
| Weighted Alpha | -24.52 | +39.33 | +15.42 | ||
| Today's Opinion | 88% Sell | 88% Buy | 72% Buy | ||
| Previous Opinion | 88% Sell | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 40% Sell | 24% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.01% since 05/15/24 | -0.74% since 05/15/24 | +3.71% since 05/15/24 | ||
| Low | 40.85 on 05/16/24 | 44.30 on 05/20/24 | 160.93 on 05/16/24 | ||
| High | 43.99 on 05/22/24 | 46.16 on 05/16/24 | 174.49 on 05/22/24 | ||
| 1-Month | |||||
| %Chg | -8.48% since 04/22/24 | +17.49% since 04/22/24 | +7.63% since 04/22/24 | ||
| Low | 38.22 on 04/30/24 | 37.97 on 04/30/24 | 144.00 on 05/06/24 | ||
| High | 50.98 on 04/26/24 | 46.16 on 05/16/24 | 174.49 on 05/22/24 | ||
| 3-Month | |||||
| %Chg | -35.49% since 02/22/24 | +14.50% since 02/22/24 | +51.17% since 02/22/24 | ||
| Low | 38.22 on 04/30/24 | 37.73 on 04/19/24 | 109.57 on 02/23/24 | ||
| High | 71.90 on 02/26/24 | 46.16 on 05/16/24 | 189.97 on 03/05/24 | ||
| 6-Month | |||||
| %Chg | -8.46% since 11/22/23 | +13.39% since 11/22/23 | +65.90% since 11/22/23 | ||
| Low | 38.22 on 04/30/24 | 33.15 on 02/05/24 | 99.00 on 11/28/23 | ||
| High | 73.80 on 01/09/24 | 46.16 on 05/16/24 | 189.97 on 03/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,165,337 | 5,796,058 | 4,764,331 | ||
| Shares Outstanding, K | 121,366 | 127,274 | 28,558 | ||
| Annual Sales | 396,590,000 | 829,250,000 | 50,700,000 | ||
| Annual Net Income | -528,630,000 | 281,590,000 | 10,930,000 | ||
| Last Quarter Sales | 172,330,000 | 195,880,000 | 45,250,000 | ||
| Last Quarter Net Income | -66,420,000 | 76,820,000 | 930,000 | ||
| 60-Month Beta | 0.97 | 1.26 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/07/24 | 0.79 on 05/07/24 | 0.03 on 05/06/24 | ||
| Latest Earnings Date | 05/07/24 | 05/07/24 | 05/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.89 | 0.00 | ||